John Rogers’s Bristol-Myers Squibb BMY Stock Holding History

John Rogers’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$40.1M	Sell	696,430 -25,301	-4%	-$1.45M	0.4%	56
2026 Q1	$43.8M	Sell	721,731 -10,946	-1%	-$638K	0.49%	50
2025 Q4	$39.5M	Buy	+732,677	New	+$35.2M	0.43%	52
2024 Q4	–	Sell	-342,514	Closed	-$17.7M	–	111
2024 Q3	$17.7M	Sell	342,514 -276,697	-45%	-$13M	0.18%	85
2024 Q2	$25.7M	Sell	619,211 -14,902	-2%	-$667K	0.28%	79
2024 Q1	$34.4M	Sell	634,113 -345,635	-35%	-$17.6M	0.34%	75
2023 Q4	$50.3M	Buy	979,748 +326,789	+50%	+$17.2M	0.5%	61
2023 Q3	$37.9M	Sell	652,959 -108,249	-14%	-$6.63M	0.4%	67
2023 Q2	$48.7M	Sell	761,208 -25,255	-3%	-$1.69M	0.46%	65
2023 Q1	$54.5M	Sell	786,463 -3,203	-0.4%	-$226K	0.52%	58
2022 Q4	$56.8M	Sell	789,666 -9,868	-1%	-$744K	0.58%	55
2022 Q3	$56.8M	Sell	799,534 -14,227	-2%	-$1.03M	0.62%	52
2022 Q2	$62.7M	Buy	813,761 +17,859	+2%	+$1.36M	0.63%	54
2022 Q1	$58.1M	Buy	795,902 +5,197	+0.7%	+$349K	0.52%	58
2021 Q4	$49.3M	Sell	790,705 -62,684	-7%	-$3.68M	0.42%	66
2021 Q3	$50.5M	Buy	853,389 +279,410	+49%	+$18.4M	0.46%	61
2021 Q2	$38.4M	Sell	573,979 -126,655	-18%	-$8.26M	0.36%	66
2021 Q1	$44.2M	Buy	700,634 +445,836	+175%	+$27.7M	0.44%	63
2020 Q4	$15.8M	Sell	254,798 -69,158	-21%	-$4.25M	0.18%	84
2020 Q3	$19.5M	Sell	323,956 -32,440	-9%	-$1.95M	0.28%	75
2020 Q2	$21M	Buy	356,396 +221,890	+165%	+$13.3M	0.32%	73
2020 Q1	$7.5M	Buy	+134,506	New	+$8.22M	0.13%	92

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

John Rogers's BMY Position: Q2 2026 in Review

John Rogers reduced its Bristol-Myers Squibb (BMY) stake by 3.5% in Q2 2026, selling an estimated $1.45M and leaving 696,430 shares worth $40.1M. The position accounts for 0.4% of the portfolio, ranked #56.

John Rogers first reported a position in BMY in Q1 2020 and has held it in 22 quarters since. The position peaked at $62.7M in Q2 2022. 2,506 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

John Rogers held 696,430 shares of Bristol-Myers Squibb worth $40.1M as of Q2 2026.
John Rogers sold 25,301 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.45M.
Bristol-Myers Squibb made up 0.4% of John Rogers's portfolio in Q2 2026, its #56 holding.
John Rogers first reported a position in Bristol-Myers Squibb in Q1 2020 and has held it in 22 quarters since.
John Rogers's Bristol-Myers Squibb position peaked at $62.7M in Q2 2022.
2,506 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Ariel Investments's 13F filing for Q2 2026, filed 14 Aug 2026.